ERNA vs ONCO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 26, 2026

ERNA

34.5
AI Score
VS
ONCO Wins

ONCO

56.1
AI Score

Investment Advisor Scores

ERNA

35score
Recommendation
EXTENDED

ONCO

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ERNA ONCO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -94.1% -83.9% ONCO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 34.5/100 56.1/100 ONCO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

ERNA 1M: +35.5% · 3M: -56.1% ONCO 1M: -22.8% · 3M: -45.2%

Current Technical Phase

ERNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $4.89

ONCO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $0.64

Fundamentals Snapshot

Metric ERNA ONCO
Market Cap
Forward P/E -2.6 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.9% -0.8%
Gross Margin 1.0% 0.8%
Operating Margin 0.0% -131.1%
EPS -0.41 749.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ONCO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.